Brasília – The federal government is preparing to implement a new model for the procurement of drugs within the Unified Health System (SUS) starting in 2026, aiming to increase efficiency and reduce costs through more strategic purchasing mechanisms. The proposal includes leveraging Brazil’s large purchasing volume to negotiate lower prices, particularly for high-cost and complex therapies.

The model under discussion also seeks to simplify procurement processes and expand competition among suppliers, while exploring instruments such as centralized purchasing and innovative contracting strategies. Officials indicate that the initiative is part of a broader effort to modernize pharmaceutical assistance and strengthen the sustainability of the SUS, amid rising pressure from high-cost technologies and growing demand for access.

Source: Jota